Rare, Cell, and Gene Therapy
Flexible solutions for an evolving landscape
Fractional Leadership and Executive Search Solutions in Rare, Cell, and Gene Therapy
Companies developing cell, gene, and rare disease therapies face a distinct challenge in building executive teams with the precise expertise to match their science. Whether you need a Chief Medical Officer, VP of Regulatory Affairs, or seasoned Commercial and Clinical Operations leaders, the right hire can define your trajectory. With over 7,000 rare diseases affecting 400 million people globally and an industry experiencing unprecedented growth, the stakes and the opportunity are significant.
Compass was built for this space. Our deep expertise in rare disease and cell and gene therapy, combined with a network of proven senior-level talent, means we don’t just fill roles. We place executives who understand the regulatory complexity, the urgency, and the mission. From fractional leadership to full executive search, we connect you with leaders who are ready to drive your therapies forward.
Why Cell, Gene & Rare Disease Companies Choose Compass
Experience You Can Trust
- Specialized focus on rare disease, cell therapy, and gene therapy staffing
- Track record of successful placements in emerging biotech companies
- Understanding of market nuances and regulatory challenges
Startup-Focused Approach
- Flexible staffing solutions, including fractional leadership, designed for rapid-growth environments and lean organizational structures
- Experience with pre-commercial stage companies
- Ability to scale support as your company evolves
Speed to Market, Guaranteed
- Rapid deployment of qualified regulatory experts across key functional areas and programs
- Strategic hiring aligned with your development timelines, budget, and program needs
- Pre-vetted candidates with directly relevant cell, gene, and rare disease experience
- Ability to build entire functional teams quickly at any stage of growth
Partner with Compass
Let’s discuss how we can help you build the team you need to bring your revolutionary therapies to market. Contact us for a consultation with our cell and gene therapy staffing experts.
Cell, Gene & Rare Disease Therapy
Recent Placement Successes
We’ve earned our stripes working with some of the biggest names in the industry. Our track record is a testament to our ability to deliver exceptional results and exceed expectations.
How Compass’ Senior Director of Quality Assurance Positioned a Gene Therapy Developer for IND-Enabling Success
Drug development accelerators are transforming how treatments move from concept to clinic, particularly in the rare disease and gene therapy space. These organizations face unique challenges as they work to compress traditional development timelines while maintaining rigorous quality standards.
How Compass Empowered a Rare Disease and Gene Therapy Pioneer in Their IND-Enabling Studies
Therapeutics companies at the forefront of rare disease research often find themselves navigating a complex maze of scientific innovation, regulatory requirements, and resource constraints. These organizations frequently face the dual challenge of advancing cutting-edge therapies while operating within the limits of specialized talent and funding availability.
Compass Places Vice President, Clinical Development at Clinical-Stage Biotech
Compass Consulting Group, a premier staffing and recruiting firm specializing in gene therapy, cell therapy, and rare disease sectors of the life sciences industry, is pleased to announce the successful placement of a Vice President of Clinical Development at a clinical-stage biotechnology company.
Our Solutions
Fractional Leadership
Need to tackle a critical project with laser focus?
We Can HelpCritical Direct Hire Roles
Want to bolster your existing team with A-level expertise?
We Can HelpContract to Full Time
Envisioning long-term growth but need immediate support?
We Can HelpContingent Workforce
Are high-volume recruitment needs challenging your bandwidth?
We Can HelpOur Life Science Specialties
We deliver talent and strategic solutions across every phase of the life sciences asset development—from R&D to Commercialization.